AbCellera Biologics Inc. is a biotechnology company that creates an antibody discovery platform. Using artificial intelligence, it searches and analyzes the immune systems database to identify possible drugs. The company, incorporated in 2012 in Canada, has completed 156 discovery programs and is partnered with 36 other companies and has an agreement with Eli Lilly.